BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 12439932)

  • 1. p73beta inhibits transcriptional activities of enhancer I and X promoter in hepatitis B virus more efficiently than p73alpha.
    Xu ZH; Zhao MJ; Li TP
    World J Gastroenterol; 2002 Dec; 8(6):1094-7. PubMed ID: 12439932
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IL-4 suppresses the expression and the replication of hepatitis B virus in the hepatocellular carcinoma cell line Hep3B.
    Lin SJ; Shu PY; Chang C; Ng AK; Hu CP
    J Immunol; 2003 Nov; 171(9):4708-16. PubMed ID: 14568946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p73 function is inhibited by tumor-derived p53 mutants in mammalian cells.
    Di Como CJ; Gaiddon C; Prives C
    Mol Cell Biol; 1999 Feb; 19(2):1438-49. PubMed ID: 9891077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p73 transcriptional activity increases upon cooperation between its spliced forms.
    Alarcon-Vargas D; Fuchs SY; Deb S; Ronai Z
    Oncogene; 2000 Feb; 19(6):831-5. PubMed ID: 10698502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overproduced p73alpha activates a minimal promoter through a mechanism independent of its transcriptional activity.
    Takagi S; Ueda Y; Hijikata M; Shimotohno K
    FEBS Lett; 2001 Nov; 509(1):47-52. PubMed ID: 11734204
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Naturally occurring deletions/insertions in HBV core promoter tend to decrease in hepatitis B e antigen-positive chronic hepatitis B patients during antiviral therapy.
    Peng Y; Liu B; Hou J; Sun J; Hao R; Xiang K; Yan L; Zhang J; Zhuang H; Li T
    Antivir Ther; 2015; 20(6):623-32. PubMed ID: 25838313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of hepatitis B virus expression and replication by RNA interference in HepG2.2.15.
    Zhao ZF; Yang H; Han DW; Zhao LF; Zhang GY; Zhang Y; Liu MS
    World J Gastroenterol; 2006 Oct; 12(37):6046-9. PubMed ID: 17009407
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular mechanism of p73-mediated regulation of hepatitis B virus core promoter/enhancer II: implications for hepatocarcinogenesis.
    Buhlmann S; Racek T; Schwarz A; Schaefer S; Pützer BM
    J Mol Biol; 2008 Apr; 378(1):20-30. PubMed ID: 18342333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stronger enhancer II/core promoter activities of hepatitis B virus isolates of B2 subgenotype than those of C2 subgenotype.
    Qin Y; Zhou X; Jia H; Chen C; Zhao W; Zhang J; Tong S
    Sci Rep; 2016 Jul; 6():30374. PubMed ID: 27461034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adenovirus-mediated transfer of p53-related genes induces apoptosis of human cancer cells.
    Ishida S; Yamashita T; Nakaya U; Tokino T
    Jpn J Cancer Res; 2000 Feb; 91(2):174-80. PubMed ID: 10761704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p73 independent of c-Myc represses transcription of platelet-derived growth factor beta-receptor through interaction with NF-Y.
    Hackzell A; Uramoto H; Izumi H; Kohno K; Funa K
    J Biol Chem; 2002 Oct; 277(42):39769-76. PubMed ID: 12167641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Type, prevalence, and significance of core promoter/enhancer II mutations in hepatitis B viruses from immunosuppressed patients with severe liver disease.
    Günther S; Piwon N; Iwanska A; Schilling R; Meisel H; Will H
    J Virol; 1996 Dec; 70(12):8318-31. PubMed ID: 8970951
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional characterization of naturally occurring mutants (P405R and P425L) of p73alpha and p73beta found in neuroblastoma and lung cancer.
    Naka M; Ozaki T; Takada N; Takahashi M; Shishikura T; Sakiyama S; Tada M; Todo S; Nakagawara A
    Oncogene; 2001 Jun; 20(27):3568-72. PubMed ID: 11429704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HBV transcription repression in response to genotoxic stress is p53-dependent and abrogated by pX.
    Doitsh G; Shaul Y
    Oncogene; 1999 Dec; 18(52):7506-13. PubMed ID: 10602509
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p73beta-Mediated apoptosis requires p57kip2 induction and IEX-1 inhibition.
    Gonzalez S; Perez-Perez MM; Hernando E; Serrano M; Cordon-Cardo C
    Cancer Res; 2005 Mar; 65(6):2186-92. PubMed ID: 15781630
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deletion of the COOH-terminal region of p73alpha enhances both its transactivation function and DNA-binding activity but inhibits induction of apoptosis in mammalian cells.
    Ozaki T; Naka M; Takada N; Tada M; Sakiyama S; Nakagawara A
    Cancer Res; 1999 Dec; 59(23):5902-7. PubMed ID: 10606232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. KNK437 Inhibits Replication and Transcription of the Hepatitis B Virus.
    Hu K; Huang Y; Mu J; Cheng Z; Zhu X
    Bing Du Xue Bao; 2017 Jan; 33(1):24-35. PubMed ID: 30702818
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ectopic expression of p73alpha, but not p73beta, suppresses myogenic differentiation.
    Li CY; Zhu J; Wang JY
    J Biol Chem; 2005 Jan; 280(3):2159-64. PubMed ID: 15545283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two new p73 splice variants, gamma and delta, with different transcriptional activity.
    De Laurenzi V; Costanzo A; Barcaroli D; Terrinoni A; Falco M; Annicchiarico-Petruzzelli M; Levrero M; Melino G
    J Exp Med; 1998 Nov; 188(9):1763-8. PubMed ID: 9802988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SOX2 Represses Hepatitis B Virus Replication by Binding to the Viral EnhII/Cp and Inhibiting the Promoter Activation.
    Yang H; Mo J; Xiang Q; Zhao P; Song Y; Yang G; Wu K; Liu Y; Liu W; Wu J
    Viruses; 2020 Feb; 12(3):. PubMed ID: 32121397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.